Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Maeda

Showing results (131-140 of 233) with videos related to

Pageof 24
Sort By:
Microbiology Spectrum|October 11, 2022
SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG ResponseYuki Takamatsu, Kazumi Omata, Yosuke Shimizu, et al.
Biorxiv : the Preprint Server for Biology|June 15, 2022
SARS-CoV-2-neutralizing humoral IgA response occurs earlier but modest and diminishes faster compared to IgG responseYuki Takamatsu, Kazumi Omata, Yosuke Shimizu, et al.
Scientific Reports|March 20, 2019
Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1sHirotomo Nakata, Kenji Maeda, Debananda Das, et al.
Journal of Medicinal Chemistry|July 11, 2006
Design, synthesis, and biological evaluation of the combinatorial library with a new spirodiketopiperazine scaffold. Discovery of novel potent and selective low-molecular-weight CCR5 antagonistsHiromu Habashita, Masaya Kokubo, Shin-ichi Hamano, et al.
Journal of Virology|June 2, 2021
Biochemical and Structural Properties of Entecavir-Resistant Hepatitis B Virus Polymerase with L180M/M204V MutationsShogo Nakajima, Koichi Watashi, Takanobu Kato, et al.
Journal of Virology|July 29, 2004
Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitroKenji Maeda, Hirotomo Nakata, Yasuhiro Koh, et al.
Journal of Molecular Biology|July 2, 2008
Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibitionKenji Maeda, Debananda Das, Philip D Yin, et al.
Biophysical Journal|April 8, 2023
Engineering a membrane-binding protein to trimerize and induce high membrane curvatureAli Asghar Hakami Zanjani, Anna Mularski, Anne Sofie Busk Heitmann, et al.
Scientific Reports|April 4, 2025
A high-throughput, fully automated competition assay to evaluate SARS-CoV-2 neutralizing responses and epitope specificity in clinical samplesYusuke Atarashi, Jeeeun Kim, Yasuhiro Irino, et al.
Journal of Epidemiology|March 27, 2012
Self-reported snoring frequency and incidence of cardiovascular disease: the Circulatory Risk in Communities Study (CIRCS)Mako Nagayoshi, Takeshi Tanigawa, Kazumasa Yamagishi, et al.
Pageof 24

Showing results (131-140 of 233) with videos related to

Sort By:
Pageof 24
Microbiology Spectrum|October 11, 2022
SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG ResponseYuki Takamatsu, Kazumi Omata, Yosuke Shimizu, et al.
Biorxiv : the Preprint Server for Biology|June 15, 2022
SARS-CoV-2-neutralizing humoral IgA response occurs earlier but modest and diminishes faster compared to IgG responseYuki Takamatsu, Kazumi Omata, Yosuke Shimizu, et al.
Scientific Reports|March 20, 2019
Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1sHirotomo Nakata, Kenji Maeda, Debananda Das, et al.
Journal of Medicinal Chemistry|July 11, 2006
Design, synthesis, and biological evaluation of the combinatorial library with a new spirodiketopiperazine scaffold. Discovery of novel potent and selective low-molecular-weight CCR5 antagonistsHiromu Habashita, Masaya Kokubo, Shin-ichi Hamano, et al.
Journal of Virology|June 2, 2021
Biochemical and Structural Properties of Entecavir-Resistant Hepatitis B Virus Polymerase with L180M/M204V MutationsShogo Nakajima, Koichi Watashi, Takanobu Kato, et al.
Journal of Virology|July 29, 2004
Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitroKenji Maeda, Hirotomo Nakata, Yasuhiro Koh, et al.
Journal of Molecular Biology|July 2, 2008
Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibitionKenji Maeda, Debananda Das, Philip D Yin, et al.
Biophysical Journal|April 8, 2023
Engineering a membrane-binding protein to trimerize and induce high membrane curvatureAli Asghar Hakami Zanjani, Anna Mularski, Anne Sofie Busk Heitmann, et al.
Scientific Reports|April 4, 2025
A high-throughput, fully automated competition assay to evaluate SARS-CoV-2 neutralizing responses and epitope specificity in clinical samplesYusuke Atarashi, Jeeeun Kim, Yasuhiro Irino, et al.
Journal of Epidemiology|March 27, 2012
Self-reported snoring frequency and incidence of cardiovascular disease: the Circulatory Risk in Communities Study (CIRCS)Mako Nagayoshi, Takeshi Tanigawa, Kazumasa Yamagishi, et al.
Pageof 24